Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-011504
Filing Date
2015-02-23
Accepted
2015-02-23 17:41:51
Documents
1
Period of Report
2015-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v402183_4.html 4  
1 OWNERSHIP DOCUMENT v402183_4.xml 4 20549
  Complete submission text file 0001144204-15-011504.txt   22101
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 AVENUE DE L?OPERA PARIS I0 75002
Business Address 47 AVENUE DE L?OPERA PARIS I0 75002 01-83-79-81-91
Ventech Capital II (Reporting) CIK: 0001604072 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36672 | Film No.: 15641128